ATESSIA is pleased to announce the publication of the new Atessia Journal fully dedicated to biosimilar medicines. Atessia wanted to bring you its expertise by offering you its analysis of the French market and regulations regarding biosimilar drugs.
You will also find a retrospective of the news published on Atessia Intelligence on this subject between 2019 and 2020.
This Atessia Journal is available for free with a subscription to Atessia Intelligence!